Skip to main content
Clinical Trials/ChiCTR-IPC-14005596
ChiCTR-IPC-14005596Active, not recruitingPhase 1

杂交血液净化对严重脓毒症患者多脏器保护的疗效及机制探讨

山东省自然科学基金1 site in 1 country160 target enrollmentStarted: May 1, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
160
Locations
1
Primary Endpoint
白细胞介素-6

Study Overview

Brief Summary

杂交血液净化对严重脓毒症患者多器官功能障碍的防治作用和机制。

Study Design

Study Type
干预性研究
Primary Purpose
队列研究

Eligibility Criteria

Ages
18 to 80 (—)
Sex
All

Inclusion Criteria

  • •年龄 18~80 岁;符合严重脓毒症及感染性休克诊断标准,参考标准:
  • •1.Dellinger RP, Levy MM, Rhades A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock,2012[J]. Intensive Care Med, 2013, 39(1):165-
  • •2.高戈,冯喆,常志刚,等. 2012 国际严重脓毒症及脓毒性休克诊疗指南[J].中华危重病急救医学,2013,25(8):501-505.

Exclusion Criteria

  • •恶性肿瘤晚期、终末临终状态、严重类风湿及风湿性疾病、心源性休克、梗阻性休克、免疫严重缺陷者〔如获得性免疫缺陷病毒(HIV)感染者〕、妊娠期女性、白血病及拒绝配合者。

Arms & Interventions

HBP

杂交血液净化

Intervention: 杂交血液净化

低分子肝素组

低分子肝素

Intervention: 低分子肝素

他汀组

阿托伐他汀

Intervention: 阿托伐他汀

Outcomes

Primary Outcomes

白细胞介素-6

降钙素原

肿瘤坏死因子-α

高迁移率族蛋白-1

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
山东省自然科学基金

Study Sites (1)

Loading locations...

Similar Trials